Lord Abbett Developing Growth’s performance extremes can test investors’ mettle, but it has delivered for small-growth investors who can stay focused on long-term results.
Lord Abbett Developing Growth A LAGWX
- NAV / 1-Day Return 22.25 / +1.88 %
- Total Assets 2.5 Bil
-
Adj. Expense Ratio
- Expense Ratio 0.920%
- Distribution Fee Level Low
- Share Class Type Front Load
- Category Small Growth
- Investment Style Small Growth
- Min. Initial Investment 1,000
- Status Open
- TTM Yield 0.00
- Turnover 128%
USD | NAV as of Oct 04, 2024 | 1-Day Return as of Oct 04, 2024, 10:29 PM GMT+0
Morningstar’s Analysis LAGWX
Will LAGWX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 19.7
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Krystal Biotech Inc | 2.12 | 51.2 Mil | Healthcare |
Piper Sandler Cos | 2.08 | 50.3 Mil | Financial Services |
Blueprint Medicines Corp | 2.00 | 48.4 Mil | Healthcare |
CyberArk Software Ltd | 1.99 | 48.1 Mil | Technology |
Glaukos Corp | 1.99 | 48.0 Mil | Healthcare |
Agilysys Inc | 1.96 | 47.3 Mil | Technology |
Varonis Systems Inc | 1.95 | 47.2 Mil | Technology |
Crane Co | 1.95 | 47.1 Mil | Industrials |
TransMedics Group Inc | 1.90 | 46.0 Mil | Healthcare |
AppFolio Inc Class A | 1.78 | 42.9 Mil | Technology |